Pathway Choice Prime (NY) 7-Year with ROP review

Yes, for the right buyer — specifically a New York resident who wants a fixed rate locked for seven years with no market value adjustment risk and a built-in return-of-premium guarantee. It is not the right product for someone who needs flexibility before year seven, who lives outside New York, or who is primarily looking for growth tied to market indices.

The rational case here is straightforward: someone wants to know exactly what their money will earn over seven years, wants to guarantee they can never lose principal to market movement, and values the added safety net of the ROP rider in case life changes. That buyer is likely moving retirement dollars out of a maturing CD or prior annuity and wants simplicity — one rate, one guarantee, no ongoing management decisions. The extended care waiver is a secondary draw for buyers who want a release valve if health changes during the surrender period.

I think this annuity is best for a New York resident in their late 50s to mid-70s who has longer-term retirement savings they do not need for day-to-day expenses, wants guaranteed returns without any equity risk, and appreciates a contractual promise that they can always recover at least their initial deposit. It works well inside a traditional IRA, Roth IRA, or SEP IRA given its RMD-friendly design. It is less appealing for someone who might want the money sooner, someone outside New York, or someone who wants any chance at index-linked upside.

You are buying a fixed-rate insurance contract that locks in a specific annual crediting rate for seven years and guarantees your principal cannot be eroded by market performance. The insurer holds your premium and credits interest at the declared rate each year. The Return of Premium feature means that even in a full surrender scenario during the charge period, you are contractually entitled to receive at least your original premium back. That is a floor that not every MYGA offers, and it matters particularly in New York where state regulations create their own product environment.

Pathway Choice Prime (NY) is a flexible premium deferred annuity during the first 60 days — meaning you can add additional premium of at least $100 during that window — and a single-premium product thereafter. The fixed rate is declared at contract issue and guaranteed for the full seven-year surrender period, which removes the rate-reset risk common in some fixed annuities. Rate banding applies: contracts under $100,000 earn the low-band rate, contracts of $100,000 or more earn the mid-band rate, and contracts of $250,000 or more earn the high-band rate. As of the April 2026 rate sheet, those rates are 4.15%, 4.35%, and 4.40% respectively, with upcoming rates of 4.25%, 4.45%, and 4.50% effective May 2026. These are current rates and will change with new business — the guarantee is the rate locked at your contract's issue, not the rates shown here.

The Extended Care Waiver is the most meaningful secondary feature. If you are confined to a nursing facility or require home health care services that meet the policy definition, the waiver eliminates surrender charges on withdrawals related to that event. For a seven-year product sold primarily to retirement-age buyers, that is a real protection. It acknowledges that health circumstances can change over a long surrender period and gives a contractual release valve that does not depend on the general illness waiver many products offer. The death benefit also pays the full account value to beneficiaries, which avoids a pro-rated death benefit design seen on some discount-rate products.

Free withdrawals are available starting after the first contract anniversary — up to 10% of the previous account anniversary value — as long as a $2,000 minimum account balance remains. That is a standard provision for this product type, and it covers situations like taking an annual income stream from the interest earned without triggering a charge.

Withdrawals above the free amount are subject to the charge schedule below. There is no market value adjustment on this product, which is a meaningful distinction from many MYGAs. It means the effective penalty for early exit is predictable — exactly the schedule percentage, nothing more.

Terminal illness and extended care waivers are available, and the contract is RMD-friendly — required minimum distributions attributable to the contract are handled without triggering surrender charges. That makes this a workable option inside an IRA for buyers managing RMD timing.

There are no base contract fees and no rider fees on this product. The main tradeoff is structural: you are accepting a seven-year lock in exchange for the guaranteed rate and the ROP protection. Charges start at 9% in year one and decline to 3% in year seven. Even with the ROP floor, exiting in the early years means paying a meaningful surrender charge against your accumulated value — you may recover principal but you will sacrifice a portion of credited interest.

The rate banding is a secondary consideration. If your deposit is close to $100,000 or $250,000, the rate step-up is real enough to factor into how you structure the purchase. A contract of $99,000 earns 4.15% while a $100,000 contract earns 4.35% under the April 2026 rates — a 0.20% difference compounded over seven years is not trivial.

Legal Entity: The United States Life Insurance Company in the City of New York

Parent: Corebridge Financial

A.M. Best Rating: A